WHO ICTRP trial
Exploration and research on the optimal anticoagulation strategy during…
ChiCTR2300069157 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300069157 |
|---|---|
| Public title | Exploration and research on the optimal anticoagulation strategy during cardiopulmonary bypass in neonates with congenital heart disease |
| Scientific title | Exploration and research on the optimal anticoagulation strategy during cardiopulmonary bypass in neonates with congenital heart disease |
| Primary sponsor | Fuwai Hospital, National Center for Cardiovascular Diseases |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | neonatal congenital heart disease |
| Interventions | Pre-experimental control group:Injected heparin dose is 400U/kg;Pre-experimental high-dose group 1:Injected heparin dose is 500U/kg;Pre-experimental high-dose group 2:Injected heparin dose is 600U/kg;control group:Injected heparin dose is… |
| Registration date | Mar 8, 2023 |
| Target size | Pre-experimental control group:10;Pre-experimental high-dose group… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: